Healthcare (Insights) Archives

About
Expertise
Services
Insights
- Capstone Insights
- Newsroom
Contact Us
Client Portal

COVID-19 State Reopening Tracker

by Hallie Ryan | Nov 11, 2020 | Healthcare (Insights), Insights

Winter is coming, and with it, another wave of new Coronavirus cases October 1, 2020 – Capstone believes states removing restrictions on indoor gatherings, entering the fall season, will lead to a third wave of new COVID-19 cases by November, possibly coinciding...

Opioid Litigation Focus Will Shift to Chain Pharmacies

by Hallie Ryan | Sep 28, 2020 | Healthcare (Insights), Insights

Walgreens, CVS, Rite Aid, and Walmart face $30 billion-35 billion in liabilities. August 14, 2020 – Capstone believes the focus of state attorneys general and municipalities opioid litigation will shift to chain pharmacies—primarily Walgreens Boots Alliance Inc....

Emerging Privacy Legislation and its Risks to a Healthcare Tech Company’s Business Model

by Admin | Aug 24, 2020 | Healthcare (Insights), Insights

The Request: Capstone advised a client on the potential acquisition of a healthcare analytics company that paired bolstered, value-added overlays to healthcare provider contact data. Specifically, we analyzed regulation, legislation, and other government initiatives...

340B Reform and the Risks to a Hospital-Based Specialty Pharmacy

by Admin | Jun 30, 2020 | Healthcare (Insights), Insights

The Request: Capstone advised a client on the potential acquisition of a US company that provides 340B-focused retail and specialty pharmacy management. Our diligence focused on determining the likelihood, rationale, and impact of federal and state 340B reforms to the...

Federal Surprise Medical Bill Reform—Team Health and Envision

by Admin | May 6, 2020 | Healthcare (Insights), Insights

Our Call: Capstone first wrote in December 2018 that federal surprise medical bill legislation—recently introduced in the US Senate—was likely to garner significant momentum in 2019 and pose a meaningful risk to physician staffing companies, particularly those with...

Next Entries »

NORTH AMERICA

WASHINGTON, DC
1401 New York Ave NW, Ste 600
Washington, DC 20005
202-449-9862

NEW YORK
420 Lexington Ave, Ste 940
New York, NY 10170

HOUSTON
3040 Post Oak Blvd, Ste 1000
Houston, TX 77056

EUROPE

LONDON
7 Howick Place
London, SW1P 1BB

PARIS
27 Avenue de l'Opéra, Ste 412
75001 Paris, France

ASIA

MUMBAI
Dextrus, B Block/ Wing, 11th Floor, One BKC
Plot no. C-66, G Block, Bandra Kurla Complex
Bandra East, Mumbai - 400051

Subscribe
Stay up to date with our latest insights

ABOUT
AREAS OF EXPERTISE
SERVICES
INSIGHTS
CONTACT
NEWSROOM
COMPLIANCE
© 2025 Capstone DC, Privacy Policy

The investment adviser or investment adviser representative in question may only transact business in this state if first licensed, excluded, or exempted from the state investment adviser or investment adviser representative licensing requirements; and individualized responses to persons in this state by the investment adviser or investment adviser representative that involve either effecting or attempting to effect transactions in securities, or rendering of personalized investment advice for compensation, will not be made without compliance with the state investment adviser or investment adviser representative licensing requirements, or an applicable exemption or exclusion.

Contact Us

A Supplemental Benefits Vendor

We added value by…

Predicting the policy landscape in US healthcare to anticipate major changes impacting its markets

Quantifying the impact of these likely changes on the company’s revenue drivers, such as federal health programs and employer insurance markets

Creating a strategy for C-suite leadership to inform new market entry, revenue optimization, and effectively execute stakeholder building, communications, and advocacy